Please assess the completion status of the following clinical trial:

Trial Title: Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* War-zone and non-war-zone veterans~* Ages 18-60 years old~* Males and females~* Able to read, speak, and understand English~* Medical records showing prior diagnosis of PTSD (here it refers to the records prior to TILS, which will be assessed and obtained in Visit 1)~* Medical records showing diagnosis of PTSD (here it refers to the CAPS-5 record prior to TILS, which will be assessed and obtained in Visit 1)~* On stable doses of any psychotropic medications for at least 4 weeks~Exclusion Criteria:~* Significant physical disability to perform a computerized memory task~* Past/current significant medical/neurological/mental health disorders known to affect cognitive functioning (e.g., stroke, dementia, schizophrenia, AIDS)~* Presence of moderate/severe TBI, defined as having: alteration of consciousness/mental state \>24 hours; posttraumatic amnesia \>1 day; loss of consciousness \>30 minutes; and/or abnormal structural neuroimaging. We will not exclude veterans with mild TBI, which is found in nearly 50% of veterans with PTSD~* Alcohol abuse/dependence for the past 12- months, as determined by the Rapid Alcohol Problems Screen score \>0~* Drug abuse/dependence for the past 12- months, as determined by the Drug Abuse Screening Test-10 score \>2~* Severe depression (PHQ-9 total score \>19), significant risk of suicide (SBQ-R \>6), severe headache (PHQ-15, Item e =2), and/or severe dizziness (PHQ-15, Item g =2)~* Opiate use in the month prior to study entry

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- One TILS, one sham, and then five TILS interventions (Type: EXPERIMENTAL): Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.
- One sham, then six TILS interventions (Type: EXPERIMENTAL): Participants first received a sham session, followed by six weekly TILS sessions.

Based on this trial design, predict the completion outcome and termination type (if applicable).